CYP3A4 Cancer Research Results
CYP3A4, CYP3A4: Click to Expand ⟱
| Source: |
| Type: |
CYP3A4 is the most abundant cytochrome P450 enzyme in the liver and is also expressed in extrahepatic tissues.
– It metabolizes a wide range of drugs and endogenous substrates, including hormones.
– In some studies, higher CYP3A4 expression has been correlated with poorer response to treatment and potentially worse survival.
|
Scientific Papers found: Click to Expand⟱
*BioAv↓, Half-Life∅, *BioAv↓, Dose∅, Synergy↑, CYP1A2↓, CYP2C9↓, CYP3A4↓,
CYP3A4↓, Apoptosis↑, AntiTum↑,
Dose↝, BioAv↑, Half-Life↑, CYP3A4↓, PSA↓,
P450↓, CYP3A4↓, CYP2C9↓,
DNMTs↓, HDAC1↓, HDAC2↓, HDAC3↓, HDAC8↓, chemoPv↑, AntiCan↑, CYP3A4↓, Dose↝, GutMicro↑, Synergy↑,
Risk↓, Ingr?, *antiOx?, *Inflam↓, *Estro↓, *Ingr↑, *neuroP↑, *Obesity↓, TumMeta↓, TumCP↓, *AntiAg↑, *AntiDiabetic↑, *ROS↓, *GutMicro↑, FOXM1↓, PCNA↓, Ki-67↓, CDK2↓, Akt↓, PDGF↓, ERK↓, p‑GSK‐3β↓, IGFR↓, p‑MDM2↓, EGFR↓, FASN↓, CYP3A4↓, COX2/PTGS2↓, Cyt‑c↑, cl‑PARP↑, Casp3↑, p‑P53↑, Bcl-2↓, VEGF↓, VEGFR2/KDR/Flk1↓, BRCA1↓, BRCA2↓, survivin↓, GADD45A↓, FAK↓, pax↓, Rho↓, Rac1↓, Cdc42↓, MMP2↓, TIMP1↑, TIMP2↑, angioG↓, MMP↓, ChemoSen↑,
AntiCan↑, toxicity↓, ChemoSen↑, chemoP↑, TumCCA↑, TumCD↑, TumCI↓, angioG↓, Ferroptosis↑, Imm↑, MOMP↑, Cyt‑c↑, Casp↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, Apoptosis↑, ROS↑, TumAuto↑, GPx4↓, xCT/SLC7A11↓, RadioS↑, NRF2↓, HO-1↓, HSP90↓, Dose↝, Dose↝, BioAv↓, BioAv↝, CYP3A4↓, *toxicity↑, *toxicity↝,
Risk↓, TumCG↓, ROS↑, TumCCA↑, Apoptosis↑, Ingr?, chemoPv↑, P450↓, SXR↓, CYP3A4↓, NRF2↑, ARE↑, HO-1↑, p38↓, TrxR↑, Trx↑, NF-kB↓, AP-1↓, BioAv↑, Akt↓, STAT3↓, HDAC↓, VEGF↓, MMP2↓, Hif1a↓, CD31/PECAM-1↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, FOXO1↓, FOXO3↓, BIM↑, p27/CDKN1B↑, P21↑, HER2/EBBR2↓, EGFR↓, Bcl-xL↓, XIAP↓, ROS↓, Zeb1↓, Snail↓, E-cadherin↑, MMP2↓, MMP9↓, ROS↑, MMP↓, Casp↑, DNAdam↑, TumCCA↑, γH2AX↑, CSCs↓, OCT4↓, SOX2↓, Nanog↓, NOTCH2↑, selectivity↝, ETC↓, compI↓, compIII↓, OCR↓, Synergy↑, ChemoSen↑, RadioS↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
ChemoSen↑, CYP3A4↓, PXR, NR1I2↓, GSTA1↓, MDR1↓, MRP1/ABCC1↓, ABCG2↓,
Risk↓, AntiCan↑, TumCP↓, TumMeta↓, ChemoSen↑, *BioAv↑, *other↝, *Dose↝, Dose↓, *BioAv↑, *Dose↝, *Half-Life↝, *toxicity↝, GSH↓, ROS↑, CYP1A1↑, CYP1A2↑, P450↓, CYP2E1↑, CYP3A4↓, CYP2A3/CYP2A6↓, *ROS↓, *GPx1↑, *SOD1↑, *SOD2↑, Akt↓, EGFR↓, HER2/EBBR2↓, P53↑, Telomerase↓, selectivity↑, MMP↓, Cyt‑c↑, Apoptosis↑, DR4↑, Fas↑, XIAP↓, survivin↓, TumAuto↑, Hif1a↓, angioG↓, MMPs↓, ERK↓, NF-kB↓, EMT↓, TumCI↓, TumCMig↓, Glycolysis↓, ATP↓, selectivity↑, *antiOx↑, Dose↝, other↝, OCR↓, GSH↓, ITGB1↓, ITGB6↓, ChemoSen↑,
TumCCA↑, CYP1A1↓, CYP3A4↓, Cyt‑c↑, Casp9↑, Apoptosis↑, ROS↑, MAPK↑, P53↑, BAX↑, ChemoSen↑, HDAC↓, GSH↓, HO-1↑,
Showing Research Papers: 1 to 11 of 11
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ARE↑, 1, GPx4↓, 1, GSH↓, 3, HO-1↓, 1, HO-1↑, 2, NRF2↓, 1, NRF2↑, 1, ROS↓, 1, ROS↑, 5, Trx↑, 1, TrxR↑, 1, xCT/SLC7A11↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compI↓, 1, compIII↓, 1, ETC↓, 1, OCR↓, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ATP↓, 1, FASN↓, 1, Glycolysis↓, 1, p‑GSK‐3β↓, 1, PDK1 / PDPK1↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 5, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, BIM↑, 1, Casp↑, 2, Casp3↑, 1, cl‑Casp3↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 4, Fas↑, 1, Ferroptosis↑, 1, p‑MDM2↓, 1, MOMP↑, 1, p38↓, 1, survivin↓, 2, TumCD↑, 1, XIAP↓, 2,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 3, EGFR↓, 3, ERK↓, 2, HER2/EBBR2↓, 2, IGFR↓, 1, MAPK↑, 1, mTOR↓, 1, PI3K↓, 1, STAT3↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
DNMTs↓, 1, FOXM1↓, 1, FOXO1↓, 1, FOXO3↓, 1, HDAC↓, 2, HDAC1↓, 1, HDAC2↓, 1, HDAC3↓, 1, HDAC8↓, 1, OCT4↓, 1, other↝, 1, SOX2↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP90↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 2,
DNA Damage & Repair(tgid=10) ⓘ
BRCA1↓, 1, BRCA2↓, 1, DNAdam↑, 1, P53↑, 2, p‑P53↑, 1, cl‑PARP↑, 2, PCNA↓, 1, Telomerase↓, 1, γH2AX↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, GADD45A↓, 1, Ki-67↓, 1, P21↑, 1, p27/CDKN1B↑, 1, TumCCA↑, 4,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, Ki-67↓, 1, Nanog↓, 1, NOTCH2↑, 1, TumCG↓, 1, TumCP↓, 2,
Migration(tgid=13) ⓘ
AP-1↓, 1, Cdc42↓, 1, E-cadherin↑, 1, EMT↓, 1, FAK↓, 1, ITGB1↓, 1, ITGB6↓, 1, MMP2↓, 3, MMP9↓, 1, MMPs↓, 1, pax↓, 1, PDGF↓, 1, Rac1↓, 1, Rho↓, 1, Snail↓, 1, TIMP1↑, 1, TIMP2↑, 1, TumCI↓, 2, TumCMig↓, 1, TumMeta↓, 2, Zeb1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 3, CD31/PECAM-1↓, 1, Hif1a↓, 2, VEGF↓, 2, VEGFR2/KDR/Flk1↓, 1,
Barriers & Transport(tgid=15) ⓘ
MMP↓, 3,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, DR4↑, 1, Imm↑, 1, NF-kB↓, 2, PSA↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
PXR, NR1I2↓, 1, SXR↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ABCG2↓, 1, BioAv↓, 1, BioAv↑, 2, BioAv↝, 1, ChemoSen↑, 7, CYP1A1↓, 1, CYP1A1↑, 1, CYP1A2↓, 1, CYP1A2↑, 1, CYP2A3/CYP2A6↓, 1, CYP2C9↓, 2, CYP2E1↑, 1, CYP3A4↓, 11, Dose↓, 1, Dose↝, 5, Dose∅, 1, GSTA1↓, 1, Half-Life↑, 1, Half-Life∅, 1, MDR1↓, 1, MRP1/ABCC1↓, 1, P450↓, 3, RadioS↑, 2, selectivity↑, 2, selectivity↝, 1, Synergy↑, 8,
Clinical Biomarkers(tgid=22) ⓘ
BRCA1↓, 1, EGFR↓, 3, FOXM1↓, 1, HER2/EBBR2↓, 2, PSA↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 3, AntiTum↑, 1, chemoP↑, 1, chemoPv↑, 2, Risk↓, 3, toxicity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
GutMicro↑, 1,
Ingredients & Constituents(tgid=25) ⓘ
Ingr?, 2,
Total Targets: 157
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx?, 1, antiOx↑, 1, GPx1↑, 1, ROS↓, 2, SOD1↑, 1, SOD2↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
Estro↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 2, BioAv↑, 2, Dose↝, 2, Half-Life↝, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, neuroP↑, 1, Obesity↓, 1, toxicity↑, 1, toxicity↝, 2,
Infection & Microbiome(tgid=24) ⓘ
GutMicro↑, 1,
Ingredients & Constituents(tgid=25) ⓘ
Ingr↑, 1,
Total Targets: 21
Scientific Paper Hit Count for: CYP3A4, CYP3A4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1131 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page